The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
The FDA’s CNPV Pilot Is Reshaping Drug Development—Is Your Program Ready to Leverage It?
Read More
post
Ensuring Data Integrity in Pharma: Best Practices for Compliance
Read More
infographic
Common Hurdles Sponsors Face upon a Marketing Application Submission
Read More
post
Cloud and AI in Pharma: Driving Digital Transformation in Pharmaceutical Operations
Read More
Let's move from science to success.
Let’s Talk